Voyager Therapeutics VYGR
NASDAQ VYGR
$1.76 -0.07 (-3.56%)
At close: Nov 11, 2026 · 4:00 PM EST

Voyager Therapeutics (VYGR) Operating Interest Expenses (2014 - 2016)

Updated

Voyager Therapeutics' Operating Interest Expenses was $9.75 million in FY2015, up 400.3% from $1.95 million in FY2014.

Analysis

Voyager Therapeutics (VYGR) Operating Interest Expenses (2014 - 2016) Analysis & Trends

  • Per Business Quant data, Operating Interest Expenses in earlier years was $1.95 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Voyager Therapeutics 113.78 Mn -447.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 -150,000.00
Mar 31, 2016 -186,000.00
Sep 30, 2015 19.50 Mn
Jun 30, 2015 -1,000.00
Mar 31, 2015 -9.75 Mn
Dec 31, 2014 195,000.00
Sep 30, 2014 349,000.00
API Access

Voyager Therapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=VYGR&period=max&api_key=YOUR_API_KEY